BFRI Biofrontera Inc.

NASDAQ
$1.30

Biofrontera Inc. (BFRI) is expected to report earnings on November 12, 2026, before the market open. The consensus earnings estimate is a loss of $0.33 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.4% since its last earnings release on August 13, 2026.

Biofrontera Beat Consensus Estimates
Thursday, August 13, 2026 · 8:51 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 12
Thursday · 7:30 AM ET
Earnings Whisper
-
vs ($0.33)
Rev est $9M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.28

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics.

Sector

Healthcare

Industry

Biotechnology